Buscar
Mostrando ítems 31-40 de 970
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
(2021)
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, several circulating variants have emerged ...
Vaccination against SARS-CoV-2 and its relationship with public interest in mental health: a study between 2020-2022 in Spain
The possible relationship between vaccination against SARS-CoV-2 (COVID-19) and mental health has been largely unexplored. We investigated variations in public interest in mental health issues between the different periods ...
Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
Various human pathogenic viruses employ envelope glycoproteins for host cell receptor
recognition and binding, membrane fusion and viral entry. The spike (S) glycoprotein of
betacoronavirus SARS-CoV-2 is a homotrimeric ...
SARS-CoV-2 Vaccine development: Current Status
In the midst of the SARS-CoV-2 pandemic and its attendant morbidity and mortality, safe
and efficacious vaccines are needed that induce protective and long-lived immune responses.
Over 120 vaccine candidates worldwide ...
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
(2021)
BACKGROUND
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass ...
COVID-19 Vaccine: A comprehensive status report
The current COVID-19 pandemic has urged the scientific community internationally to find
answers in terms of therapeutics and vaccines to control SARS-CoV-2. Published investigation
mostly on SARS-CoV and to extent on ...
An urgent proposal for the immediate use of melatonin as an adjuvant to anti- SARS-CoV-2 vaccination
(ST-Bio-Life LLC, 2021)
Abstract:
Competition among pharmaceutical companies to develop safe and effective vaccines
against SARS-CoV-2 is high. However, based on the prior experience with the influenza
vaccine, up to 50% in lack of effectiveness ...
A Heuristic Approach for Determining Efficient Vaccination Plans under a SARS-CoV-2 Epidemic Model
(MDPI, 2023-02)
In this work, we propose a local search-based strategy to determine high-quality allocation of vaccines under restricted budgets and time periods. For this, disease spread is modeled as a SEAIR pandemic model. Subgroups ...
SARS-CoV-2 vaccines vacunas para COVID-19
(Instituto Nacional de Salud, 2021)
Las vacunas han sido diseñadas con el objetivo de generar una respuesta inmune en los vacunados frente al SARS-CoV-2, esto se logra a través de la exposición a la región más inmunogénica del virus, que es el dominio de ...